Resilient Lifescience received $500,000 in the Richard King Mellon Foundation’s Social-Impact Investment Pitch Competition for its device. Photo courtesy of Resilient Lifesciences.
Resilient Lifescience is testing a monitor that could detect an overdose in its early stages through a device placed on a patient’s abdomen. Photo courtesy of Resilient Lifesciences.